☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Tessa
Tessa Reports First Patient Dosing in P-Ib Clinical Trial of TT11 as 2L Treatment of Relapsed/Refractory Classical Hodgkin Lymphom...
August 17, 2022
PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)
January 22, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
